Although CD163+ TAM density was positively correlated with age (p = 0.028), no significant association between IHC variables and other clinicopathological factors including ISS stage, DS stage, bone destruction, renal failure and induction treatment were observed (Table 1). This evidence concerns the gene CD163 and kidney failure.